Secukinumab is used in the treatment of psoriasis, ankylosing spondylitis, and psoriatic arthritis.
How Secukinumab works Secukinumab is a monoclonal antibody. It exerts its effects by neutralizing the activity of a protein called IL-17A, which is responsible for the symptoms of psoriasis, psoriatic arthritis, and ankylosing spondylitis.
Common side effects of Secukinumab include the common cold, diarrhea, and upper respiratory tract infections.
MRP ₹18,750
Flat ₹100 off on first app order | Use Code: APP100 |
Flat ₹100 off on first app order
USE CODE: APP100

Download Now